Introduction {#s1}
============

Acetylcholine (ACh) is a neurotransmitter and neuromodulator that is released throughout the mammalian cortex at times of alertness and arousal ([@bib63]) in order to promote learning and memory ([@bib17]), modulate sensory perception ([@bib43]), gate plasticity ([@bib33]; [@bib46]), and enhance the detection of salient sensory cues and reinforcement ([@bib37]; [@bib48]; [@bib49]; [@bib59]). Most cortical ACh originates from subcortical nuclei in the basal forebrain [@bib30] whose long-range axons innervate broad regions of cortex and release ACh to modulate cortical function over fast and slow time scales ([@bib48]; [@bib42]). However, cholinergic interneurons are present in the cortex of mice and rats and could provide a local source of ACh. Unfortunately, the physiology and function of these cells are poorly understood and their contribution to cortical signal has been controversial.

Putative cholinergic neurons in the cortex were first identified by immunolabeling for choline acetyltransferase (ChAT), the biosynthetic enzyme that produces ACh ([@bib13]; [@bib12]), and their presence has since been corroborated by both immunohistochemical and transcriptional analyses ([@bib4]; [@bib5]; [@bib9]; [@bib15]; [@bib23]; [@bib38]; [@bib45]; [@bib53]; [@bib67]; [@bib7]). Both initial immunochemical labeling and recent single-cell transcriptomic classification [@bib52]; [@bib62]; [@bib68] demonstrate that cortical ChAT^+^ neurons also express vasoactive intestinal peptide (VIP), indicating that they are a subclass of VIP^+^ interneurons.

To date, characterization of the synaptic connectivity of cortical ChAT^+^ neurons has been limited, describing primarily cholinergic effects on downstream neurons, with little or no GABAergic effects as might be expected from a subclass VIP^+^ interneurons. Von Engelhardt and colleagues reported that cortical ChAT^+^ neurons release ACh that opens nicotinic ACh receptors (nAChRs) on excitatory pre-synaptic terminals to increase synaptic release of glutamate ([@bib65]). A recent study by Obermayer et al found that cortical ChAT^+^ neurons directly excite several interneuron subtypes as well as deep layer pyramidal neurons via nAChRs ([@bib35]). These studies argue strongly for a primarily cholinergic role for these neurons. However, they did not comprehensively survey post-synaptic connectivity across cortex.

Whether cortical ChAT^+^ neurons also release gamma-aminobutyric acid (GABA) is even less clear. Several studies have reported GABA synthetic enzyme expression in only a subset of cortical ChAT^+^ neurons ([@bib23]; [@bib65]), whereas others have reported widespread co-labeling with GABA ([@bib2]). Although the synaptic outputs of cortical ChAT^+^ neurons have either been described as entirely cholinergic ([@bib65]) or partially GABAergic ([@bib35]), activation of cortical ChAT^+^ neurons in vivo suppresses responses to sensory input ([@bib11]). This could occur either through directly via GABAergic inhibition or indirectly by cholinergic excitation of intermediate inhibitory interneurons. Given their expression of VIP, a marker gene for a cardinal class of GABAergic interneurons, one would expect cortical ChAT^+^ neurons to be GABAergic, but this has not been definitively shown.

We previously reported that co-transmission of GABA is a common feature of cholinergic neurons in the mouse forebrain ([@bib50]; [@bib16]; [@bib51]). Because GABA and ACh have opposite effects on membrane voltage through ionotropic receptors, the functional consequences of their co-transmission on cortical circuits is unknown. One possibility is that they each transmit onto the same post-synaptic targets and have competing effects, similar to the co-release of GABA and glutamate in the habenula from entopeduncular neurons ([@bib55]; [@bib66]) or co-release of ACh and GABA from starburst amacrine cells onto direction-selective retinal ganglion cells ([@bib25]; [@bib54]). Another possibility is that they target different post-synaptic cells, which could allow them to have complementary network effects. To differentiate between these alternatives requires determining the molecular competency of cortical ChAT^+^ neurons to release GABA and ACh from their pre-synaptic terminals, and systematic examination of their synaptic connectivity.

To answer these many unknowns, we molecularly and functionally characterized cortical ChAT^+^ neurons and describe two classes of cortical ChAT^+^ neurons. The first is a subset of VIP^+^ interneurons, and expresses the necessary cellular machinery to synthesize and release both ACh and GABA. A systematic survey of synaptic connectivity shows that, for these cells, most synaptic output is GABAergic. Specifically, GABA release is robust onto somatostatin (Sst)-expressing interneurons, similar to the larger population of VIP^+^ interneurons. However, these cells are capable of releasing ACh, with sparse and highly specific targeting of ACh mostly onto layer 1 interneurons and other cortical VIP^+^/ChAT^+^ neurons. Target-specificity is partially specified at the pre-synaptic level, as we identified two distinct populations of pre-synaptic terminals: a subset that are competent to release both GABA and ACh and others that can only release GABA. The second class of cortical ChAT^+^ interneurons is molecularly and functionally distinct from VIP^+^ cholinergic interneurons and was discovered in an effort to reconcile our results with those of another study that described predominantly ACh, and not GABA release, from cortical ChAT^+^ interneurons ([@bib35]). This sparse population of non-VIP ChAT^+^ neurons is found in the mPFC, has a distinct developmental origin from VIP^+^ interneurons, and contributes primarily cholinergic signaling. Thus, ChAT^+^ interneurons are heterogeneous across cortical regions, comprise an intra-cortical source of highly specific synaptic ACh, and show target-specific co-transmission of two distinct neurotransmitters.

Results {#s2}
=======

Cortical VIP^+^/ChAT^+^ neurons express genes for release of both ACh and GABA {#s2-1}
------------------------------------------------------------------------------

To visualize potential cholinergic neurons in the cortex, we genetically labeled all *Chat*-expressing cells with tdTomato (*Chat^ires-Cre^* x *Rosa26^lsl-tdTomato^*), and observed putative cholinergic neurons throughout the cortex ([Figure 1A](#fig1){ref-type="fig"}). We confirmed that *Cre* expression faithfully reports *Chat* expression in cerebral cortex using fluorescent in situ hybdrization (FISH), with 97% of *Chat^+^* neurons expressing *Cre* and 100% of *Cre*^+^ neurons expressing *Chat* ([Figure 1B](#fig1){ref-type="fig"}). In contrast, a population of neurons in the subiculum are also strongly labeled in *Chat^ires-Cre^* x *Rosa26^lsl-tdTomato^* mice ([Figure 1A](#fig1){ref-type="fig"}), but do not express *Chat* in the adult (data not shown). In addition to *Chat,* neurons also require the expression of the membrane choline transporter, encoded by *Slc5a7*, and the vesicular ACh transporter (VAChT), encoded by *Slc18a3,* to synthesize and release ACh. Both of these genes are also expressed in the majority of cortical ChAT^+^ neurons ([Figure 1C,D](#fig1){ref-type="fig"}), indicating that cortical ChAT^+^ neurons have all the molecular machinery necessary to release ACh. These neurons display a vertically-oriented morphology, with their main dendrites aligned perpendicular to the cortical surface, and are either bipolar, with two main vertical dendrites ([Figure 1E](#fig1){ref-type="fig"}, 66% of all cortical ChAT^+^ neurons) or multipolar, with three or more main dendrites ([Figure 1E](#fig1){ref-type="fig"}, 34% of all cortical ChAT+ neurons). They cluster in superficial layers, especially near the border between layers 1 and 2 ([Figure 1F](#fig1){ref-type="fig"}).

![Cortical ChAT^+^ neurons are present throughout cortex and express genes necessary for synthesis and release of ACh.\
(**A**) Sagittal view of a mouse neocortex with ChAT^+^ neurons expressing tdTomato (*Chat^ires-Cre^* x *Rosa26^lsl-tdTomato^*) demonstrating the distribution of putative cholinergic neurons throughout the cortex. Strongly tdTomato-labeled neurons in the subiculum that do not express *Chat* are labeled (SUB). (**B**) Flourescent in situ hybridization of *Cre* faithfully reports *Chat* expression in *Chat^ires-Cre^* mice in the cortex. Arrow heads indicate dual *Chat*^+^/*Cre*^+^ neurons. Quantification shown at right (n = 32 *Chat*^+^/*Cre*^+^ of 33 *Chat*^+^ and 32 *Cre*^+^ neurons from 2 *Chat^ires-Cre^* mice). (**C,D**) Fluorescent in situ hybrization of *Chat* in cortex co-labels with *Slc18a3*, the gene encoding VAChT (n = 147 *Chat*^+^/*Slc18a3*^+^ of 170 *Chat*^+^ and 184 *Slc18a3*^+^ neurons from 3 wild-type mice) and *Slc5a7*, the gene encoding the membrane choline transporter (n = 72 *Chat*^+^,*Slc5a7*^+^ of 113 *Chat*^+^ and 83 *Slc5a7*^+^ neurons from 3 wild-type mice). Arrowheads indicate cortical ChAT*^+^* neurons and quantification shown at right. (**E**) Cortical ChAT^+^ neurons are vertically oriented and are bipolar (left) or multipolar (right). (**F**) Distribution of cortical depth from the pia of all cortical ChAT^+^ neurons (left graph, black trace, n = 1059 neurons from 3 *Chat^ires-Cre^* x *Rosa26^lsl-tdTomato^* mice), median cell body is 274 µm from pia ±15 µm, 95% C.I.) and according to morphology (right graph; orange = bipolar, n = 207, 66% of total, median 293 µm from pia ±23 µm, 95% C.I.; blue = multipolar, n = 107 neurons, 34% of total, median 173 µm from pia ±24 µm, 95% C.I.). Inset image is aligned to the relative depth shown in the graphs.](elife-57749-fig1){#fig1}

Previous studies have reported conflicting results on the extent to which these neurons are GABAergic, and they are often shown to co-label with vasoactive intestinal peptide (VIP) ([@bib12]). We confirmed using both immunohistochemistry and FISH that cortical ChAT^+^ neurons comprise an \~33% subset of VIP^+^ interneurons ([Figure 2A,B](#fig2){ref-type="fig"}), and do not co-label with either parvalbumin (PV) or somatostatin (Sst, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To test whether cortical ChAT^+^ neurons are able to release GABA, we performed FISH for the GABA handling and synthesis genes *Slc32a1*, encoding the vesicular GABA transporter (VGAT), and *Gad1,2*, which encode the GABA synthetic enzymes. Nearly all cortical ChAT*^+^* neurons express both *Slc32a1* and *Gad1,*2 ([Figure 2C](#fig2){ref-type="fig"}). These results are corroborated by single-cell RNA sequencing data from the Allen Institute ([@bib62]), indicating that a subset of *Vip-*expressing cortical interneurons also express cholinergic genes *Chat, Slc5a7, Slc18a3*, and GABAergic genes *Slc32a1, Gad1,* and *Gad2*, but not glutamatergic genes ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In sum, these data show that cortical VIP^+^/ChAT^+^ interneurons have the potential for synaptic release of both ACh and GABA.

![Cortical ChAT^+^ neurons are a subset of VIP^+^ interneurons and express genes necessary for synthesis and release of GABA.\
(**A**) Cortical ChAT^+^ neurons expressing tdTomato (*Chat^ires-Cre^* x *Rosa26^lsl-tdTomato^*) co-label with immunostained VIP (n = 127 ChAT^+^/VIP^+^ neurons of 147 total ChAT^+^ and 375 VIP^+^ neurons from 3 *Chat^ires-Cre^* x *Rosa26^lsl-tdTomato^* mice). (**B**) Fluorescent in situ hybridization of *Chat* in cortex co-labels with *Vip* (n = 278 *Chat*^+^/*Vip*^+^ of 283 *Chat*^+^ and 579 *Vip*^+^ neurons from 3 wild-type mice). (**C**) Fluorescent in situ hybridization labeling of *Chat* in cortex co-labels with the GABAergic genes *Slc32a1*, which encodes for VGAT, and *Gad1* and *Gad2*, which encodes for the GABA synthetic enzymes GAD67 and GAD65, respectively (n = 101 *Chat*^+^,*Slc32a1*^+^ and 102 *Chat*^+^,*Gad1/2*^+^ of 102 *Chat*^+^ neurons from 5 wild-type mice). Arrowheads indicate double labeled neurons.](elife-57749-fig2){#fig2}

Cortical VIP^+^/ChAT^+^ neurons robustly release GABA onto inhibitory interneurons and sparsely release ACh {#s2-2}
-----------------------------------------------------------------------------------------------------------

To confirm which neurotransmitters VIP^+^/ChAT^+^ neurons release and understand the circuit function these different neurotransmitters provide, we electrophysiologically screened for the post-synaptic output of cortical ChAT^+^ neurons. In order to identify synaptic outputs, as opposed to possible effects of volume transmission, we focused on synaptic effects mediated by activation of post-synaptic ionotropic receptors. We virally delivered Cre-dependent ChR2-mCherry (AAV(8)-DIO-ChR2-mCherry) into the motor cortex of *Chat^ires-Cre^* mice, and allowed three weeks for viral gene expression, prepared acute brain slices and recorded whole-cell voltage clamp responses from ChR2-lacking neurons while stimulating nearby ChR2-expressing neurons with blue light ([Figure 3A](#fig3){ref-type="fig"}). We screened for post-synaptic responses mostly in primary motor cortex (M1), with some recordings in visual cortex (V1). Because we saw no differences in connectivity between these two regions, we have pooled that data here. Synaptic responses mediated by nicotinic ACh receptors (nAChRs) were identified by voltage clamping the post-synaptic neurons at −70 mV in the presence of NBQX to preclude any contamination by feed-forward glutamatergic currents, and by sensitivity to nAChR-selective antagonists ([Figure 3B](#fig3){ref-type="fig"}). We observed nAChR-mediated responses with both slow and fast components ([Figure 3B](#fig3){ref-type="fig"}), as well as several with only fast components (not shown), indicating variability in the nAChR receptor composition in post-synaptic neurons ([@bib3]). GABA~A~R-mediated synaptic currents were identified by voltage clamping the cell at 0 mV, and by blocking with the GABA~A~R-selective antagonist gabazine. We also confirmed that GABA responses were monosynaptic by sequential block with TTX and rescue by 4AP ([Figure 3C](#fig3){ref-type="fig"}; [@bib39]), confirming they were not the result of indirect excitation of intermediate inhibitory neurons. Of the neurons that displayed a detectable synaptic response following optogenetic stimulation of the cortical ChAT^+^ neurons, most showed a GABA~A~R-mediated current, confirming that cortical ChAT^+^ neurons are indeed GABAergic. A smaller subset of neurons in superficial layers showed nAChR-mediated synaptic responses ([Figure 3D](#fig3){ref-type="fig"}). All but two (of 49) responsive neurons displayed either GABA~A~R- or nAChR-mediated currents, not both, indicating that the synaptic release of GABA or ACh by cortical ChAT^+^ neurons is independent and differentially targeted based on the output neurons.

![Cortical VIP^+^/ChAT^+^ interneurons primarily release GABA onto inhibitory interneurons and sparsely release ACh onto layer 1 and other ChAT^+^ neurons.\
(**A**) Experimental design: Cre-dependent ChR2-mCherry is virally delivered (AAV(8)-DIO-ChR2-mCherry) to the cortex, expressed for 3 weeks, and whole-cell voltage clamp recordings obtained from unlabeled neurons. Recordings from motor cortex and visual cortex are pooled for panels **A-D**. (**B**) Examples trace of a biphasic nAChR-mediated synaptic currents isolated by voltage clamping the post-synaptic neuron at −70 mV and stimulating cortical ChAT^+^ neurons with 3 ms of 473 nm light (\~7--9 mW/cm^2^). The synaptic current is insensitive to AMPA receptor antagonist NBQX, but the slow component is blocked by DHβE, selective for ɑ4 receptor subunits, and the fast component is blocked by the ɑ7-selective antagonist MLA and pan-nAChR antagonist MEC. Right panel shows summary quantification of sensitivity to glutamatergic antagonists NBQX/CPP and nAChR antagonists DHβE, MLA, and MEC. Error bars show mean +/- s.e.m. (**C**) Example GABA~A~ receptor-mediated currents isolated by voltage clamping the post-synaptic neuron at 0 mV. Synaptic currents are blocked by voltage-gated sodium channel antagonists TTX, rescued by subsequent application of potassium channel antagonists 4AP, and further blocked by GABA~A~R-selective antagonist gabazine. Right panel shows summary quantification of the effects of nAChR antgonists, TTX, 4AP, and gabazine on inhibitory currents. (**D**) Summary of the proportion of neurons showing synaptic responses following optogenetic stimulation of cortical ChAT^+^ neurons across cortical layers. The numbers in each bar indicate the number of cells in each category. (n = 195 total neurons from 24 *Chat^ires-Cre^* mice; p=0.8627 for layer 1 compared to non-layer 1 GABA~A~R-mediated responses and p=0.0695 or layer compared to non-layer1 nAChR-mediated responses, Fisher's exact test). (**E**) Experimental design: AAV(8)-DIO-ChR2-mCherry was injected into the motor cortex of *Chat^ires-Cre^* mice crossed to different mouse lines that express GFP in specific interneuron subpopulations. (**F**) Example images showing GFP expression in 4 different mouse lines expressing GFP in different interneuron subtypes. (**G**) Summary quantification of the proportion of cells of each interneuron subtype that had synaptic responses to optogenetic stimulation of cortical ChAT^+^ neurons. The numbers in each bar indicate the number of cells in each category. (n = 64 GFP^+^ cells from 6 *Chat^ires-Cre^* x Sst-GFP (GIN) mice; n = 47 GFP^+^ cells from 4 *Chat^ires-Cre^* x PV-GFP (G42) mice; n = 95 GFP^+^ cells from 6 *Chat^ires-Cre^* x 5HT3aR-BAC^EGFP^ mice; n = 54 GFP^+^ cells from 4 *Gad2^ires-GFP^* mice; p=0.0307 for differences in GABA~A~R-responses between interneuron types, p=0.5775 for differences in nAChR-responses, Pearson's chi-squared test). (**H**) Experimental design: To achieve mosaic expression of ChR2 in a subset of cortical ChAT^+^ neurons, we injected a diluted AAV(8)-DIO-FlpO virus so that a subset would express Flp. We then injected with high-titer AAV(8)-fDIO-ChR2-EYFP and AAV(8)-DIO-mCherry. We targeted mCherry^+^, EYFP^-^ cells for whole-cell voltage clamp recording that neighbored EYFP^+^ neurons. (**I**) Example traces showing putative GABA~A~R-mediated synaptic response at baseline and following application of TTX, 4AP, and gabazine. Right panel shows summary quantification of block by TTX, rescue by 4AP, and block by gabazine. Error bars show mean ± s.e.m. (**J**) Example traces of two different neurons showing nAChR-mediated responses and their block by nAChR antagonists and TTX. These two cells have different response kinetics, potentially indicative of extra-synaptic (top) and synaptic (bottom) nAChRs. Right panel shows summary quantification of putative nAChR-mediated synaptic response sensitivity to nAChR antagonists (MEC, MLA, and DHβE) and TTX. (**K**) Summary quantification of the proportion of cortical ChAT^+^ neurons that showed synaptic responses following stimulation of neighboring ChR2-expressing cells. The numbers in each bar indicate the number of cells in each category (n = 76 neurons from 8 *Chat^ires-Cre^* mice).](elife-57749-fig3){#fig3}

To identify onto which neuron populations cortical ChAT^+^ neurons synapse and therefore inform the potential circuit function of both ACh and GABA release, we systematically surveyed connectivity to specific neuronal subtypes. We repeated the ChR2-assisted connectivity survey described above, but in *Chat^ires-Cre^* mice crossed with transgenic lines that express GFP in the major interneuron populations, including Sst^+^ ([@bib36]), PV^+^ ([@bib6]), and 5HT3aR^+^ interneurons ([@bib26]; [Figure 3E,F](#fig3){ref-type="fig"}). We found high rates of GABAergic connectivity, especially onto Sst^+^ interneurons, while nAChR-mediated responses were rare ([Figure 3G](#fig3){ref-type="fig"}). While Sst^+^, PV^+^, and 5Ht3aR^+^ interneurons represent nearly 100% of all cortical interneurons ([@bib47]), the Sst- and PV-labeling transgenic lines incompletely label their respective interneuron populations. We therefore also recorded responses from GFP-labeled, GAD65-expressing interneurons from *Gad2^ires-GFP^* mice, and observed only GABA~A~R-mediated responses ([Figure 3G](#fig3){ref-type="fig"}). In each of these specific neuronal subtypes, we confirmed that GABA release from cortical ChAT^+^ cells was monosynaptic and confirmed that between these 4 interneuron classes, we spanned the entire cortical column ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We also targeted pyramidal neurons based on their morphology and laminar position and found a low overall rate of connectivity, which was entirely GABA~A~R-mediated ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). This pattern of connectivity is consistent with reports for VIP^+^ interneurons as a whole ([@bib40]; [@bib19]), and indicates that the main circuit function of cortical VIP^+^/ChAT^+^ interneurons is disinhibition.

While this broad connectivity survey makes clear that VIP^+^/ChAT^+^ neurons release GABA most robustly onto Sst^+^ interneurons, it is less clear exactly which neurons receive nAChR-mediated input. A subset of layer 1 interneurons, whose specific molecular identity is otherwise unknown, showed the most robust ACh-mediated responses ([Figure 3D](#fig3){ref-type="fig"}). We therefore used a candidate-based approach to test specific potential post-synaptic populations that might be most likely to receive VIP^+^/ChAT^+^ input. A previous study has reported that non-Martinotti Sst^+^ interneurons in layer 6 can be activated by muscarinic receptors in response to sensory stimulation ([@bib34]), but the transgenic line we used to identify Sst^+^ interneurons does not effectively label deep layer neurons ([Figure 3F](#fig3){ref-type="fig"}). We therefore recorded from deep-layer Sst^+^ neurons by injecting *Chat^ires-Cre^* x *Sst^ires-Flp^* mice with viruses expressing Cre-dependent ChR2-mCherry (AAV(8)-DIO-ChR2-mCherry) and Flp-dependent EYFP (AAV(8)-fDIO-EYFP), and obtained current clamp recordings to allow for detection of muscarinic currents following trains of optogenetic stimulation. Of those cells with clear synaptic responses, we only identified hyperpolarizing currents that were sensitive to gabazine, indicating they were GABA~A~R-mediated ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Contrary to the findings of von Engelhardt et al., we did not observe any significant effect of optogenetic stimulation on pre-synaptic glutamate release ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}).

Given the ability of ACh to dilate blood vessels, and previous reports on the role of VIP^+^ interneurons in mediating vasodilation ([@bib9]; [@bib7]; [@bib21]), we also hypothesized that VIP^+^/ChAT^+^ interneurons might release ACh onto neighboring arteries, coupling an increase in cortical activity via disinhibition with an increase in blood flow to meet the increases in metabolic demand. Although we confirmed that optogenetic stimulation of VIP^+^ interneurons is sufficient to induce vasodilation, using a genetic strategy that eliminates Ach release from VIP^+^ interneurons, we found that ACh release from these cells is not necessary for optogenetic- or sensory-evoked vasodilation ([Figure 3---figure supplement 5](#fig3s5){ref-type="fig"}).

Finally, another study found that VIP^+^ interneurons can increase their firing rate through cooperative excitation via nAChRs ([@bib20]). We therefore devised a strategy to test for synaptic connectivity between VIP^+^/ChAT^+^ neurons by injecting *Chat^ires-Cre^* mice first with a diluted Cre-dependent Flp virus, followed by high titer Flp-dependent ChR2-EYFP and Cre-dependent mCherry. We then recorded from mCherry-positive, EYFP-negative neurons while stimulating with blue light ([Figure 3H](#fig3){ref-type="fig"}). We found that VIP^+^/ChAT^+^ neurons largely release GABA onto each other ([Figure 3I,K](#fig3){ref-type="fig"}), but that a subset received nAChR-input which could be blocked by nAChR-selective antagonists ([Figure 3J,K](#fig3){ref-type="fig"}). These results demonstrate that VIP^+^/ChAT^+^ neuron output is primarily GABAergic, but is able to release ACh onto highly specific sub-networks of layer 1 interneurons and other VIP^+^/ChAT^+^ neurons.

Cortical VIP^+^/ChAT^+^ pre-synaptic terminals are differentially enriched for GABA and ACh release machinery {#s2-3}
-------------------------------------------------------------------------------------------------------------

Throughout the analysis of synaptic connectivity we found robust GABAergic currents in many neurons, and only relatively few cells with nicotinic receptor-mediated currents, even though many of the post-synaptic populations we examined express nAChRs. Several scenarios could explain this finding. One possibility is that most pre-synaptic terminals of VIP^+^/ChAT^+^ neurons are incapable of releasing ACh. Alternatively, most terminals might release both ACh and GABA, which would suggest that post-synaptic sites lack the nAChRs required to generate ionotropic currents following ACh release. To distinguish between these possibilities, we used array tomography to examine the pre-synaptic release machinery present in individual presynaptic terminals of cortical ChAT^+^ interneurons in the motor cortex. We labeled the presynaptic terminals by injecting AAV-encoding Cre-dependent synaptophysin-YFP into the motor cortex of *Chat^ires-Cre^* mice ([Figure 4A,B](#fig4){ref-type="fig"}) and analyzed the expression of seven synaptic proteins relative to YFP-labeled terminals. Specifically, we labeled for Synapsin 1 as a generic pre-synaptic marker, PSD-95 and VGLUT1 to label glutamatergic synapses, Gephyrin and VGAT to label GABAergic synapses, and ChAT and VAChT to label cholinergic synapses ([Figure 4C](#fig4){ref-type="fig"}). DAPI was also used to label nuclei.

![ACh and GABA synthesis and release machinery are both expressed in the presynaptic terminals of cortical ChAT^+^ interneurons.\
(**A**) Array tomography workflow: *Chat^ires-Cre^* mice are injected with Cre-dependent Synaptophysin YFP virus (AAV(8)-DIO-Synaptophysin-YFP) to label the pre-synaptic terminals of cortical ChAT^+^ neurons (1).\~1 mm^2^ squares of tissue were then embedded in resin and cut into 70 nm slices in an array (2). (**B**) Example maximum-projection of Synaptophysin-YFP staining. (**C**) The ribbons of tissue are serially stained with antibodies against pre- and post-synaptic proteins (3). Example images show the inset from (**B**) to demonstrate the staining of pre-synaptic marker Synapsin 1, glutamatergic markers PSD-95 and VGLUT1, GABAergic markers VGAT and Gephyrin, and cholinergic markers VAChT and ChAT. (**D**) The average cross-correlation between all pairs of raw images of pre- and post-synaptic antibody stains (n = 8 image stacks from 3 *Chat^ires-Cre^* mice). (**F**) The average co-variance between all pairs of raw images specifically within a mask created by the Synaptophysin-YFP stain. Co-variance within YFP terminals is not limited to values between −1 and 1 because all antibody stains were z-scored prior to masking and calculating the co-variance, and therefore antibody signals may be more or less concentrated within the YFP mask (n = 8 image stacks from 3 mice). High covariance specifically between GABAergic and cholinergic proteins emerge when limiting analysis to signal within YFP masks (**E**), but not the entire image, where correlations between glutamatergic markers are highest (**D**). (**F**) Summary of antibody colocalization analysis. First, a 3D mask of the YFP signal is created corresponding to the ChAT^+^ presynaptic terminals. Next, each punctum of antibody signal is assigned a pixel corresponding to where a Gaussian fit of fluorescence has the highest intensity. Then, the colocalization of each antibody pixel within the YFP terminals is determined and a z-score calculated by comparing to the colocalization from 1000 rounds of randomized antibody pixel locations. (**G**) Colocalization z-scores across antibodies for all samples. Higher positive z-scores indicate relative enrichment of antibody puncta within YFP terminals compared to randomized controls, while negative scores indicate depletion of antibody puncta within YFP terminals (see [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Tissue samples from *Chat^ires-Cre^* mice are shown, as well as the VGAT antibody z-score from VGAT conditional knock-out mice (6 image stacks from 3 *Chat^ires-Cre^* x *Slc32a1^fl/fl^* mice), and VAChT antibody z-scores from *Vip^ires-Cre^* (5 image stacks from 3 mice) and *Vip^ires-Cre^* x *Slc18a3^fl/fl^* (6 image stacks from 3 mice). Dashed lines indicate ± 5 z-scores.](elife-57749-fig4){#fig4}

We first analyzed this data by calculating the global cross-correlations of image intensity across all possible pairs of synaptic markers and DAPI to reveal the baseline level of colocalization ([Figure 4D](#fig4){ref-type="fig"}, also see [@bib31]). We also examined the colocalization of synaptic markers within motor cortex cortical ChAT^+^ terminals, by calculating signal covariances specifically in the \~0.1% area of the images containing synaptophysin-YFP labeled pre-synaptic terminals (see Methods). Compared to the global cross-correlations ([Figure 4D](#fig4){ref-type="fig"}), this revealed high covariance of staining intensity for GABAergic and cholinergic markers, with little to no covariance with the glutamatergic markers ([Figure 4E](#fig4){ref-type="fig"}). Thus, the fluorescence of pre-synaptic markers of ACh and GABA release are correlated within the pre-synaptic terminals of cortical ChAT^+^ neurons, indicating that these terminals have machinery to release both ACh and GABA, but not glutamate.

We also analyzed whether GABAergic and cholinergic proteins are enriched in terminals of cortical ChAT^+^ interneurons in the motor cortex. To rigorously examine the enrichment of these synaptic proteins in cortical ChAT^+^ terminals, we quantified z-scores that measured the enrichment of each pre-synaptic antibody marker relative to randomized controls ([Figure 4F](#fig4){ref-type="fig"}; further details on analysis in methods and [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Across all samples, Synapsin-1, Gephyrin, VGAT, ChAT, and VAChT were consistently enriched within cortical ChAT^+^ interneuron terminals, whereas PSD-95 and VGLUT1 were specifically depleted ([Figure 4G](#fig4){ref-type="fig"}). Because both VAChT and VGAT expression are central to our conclusions, we validated the specificity of signals from these two antibodies using genetically mosaic conditional knockouts in which the gene encoding each protein was selectively knocked-out from VIP^+^ and ChAT^+^ neurons, respectively (*Vip^ires-Cre^ x Slc18a3*^fl*/fl,*50^ and *Chat^ires-Cre^* x *Slc32a1^fl/fl^,* [@bib64]). For each antibody, both its higher covariance with other GABAergic and cholinergic proteins and its enrichment within synaptophysin-YFP-labeled cortical VIP^+^/ChAT^+^ terminals were eliminated when we conditionally deleted VGAT or VAChT ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"} and [2](#fig4s2){ref-type="fig"}).

Given these data showing that both GABA and ACh release machinery are generally expressed in the pre-synaptic terminals, we examined whether individual terminals and axon segments of VIP^+^/ChAT^+^ neurons differ in their potential to release ACh or GABA. Pre-synaptic terminals of motor cortex VIP^+^/ChAT^+^ neurons were labeled by injection of Cre-dependent synaptophysin-mCherry AAV (AAV(8)-CAG-DIO-synaptophysin-mCherry) into the motor cortex of *Chat^ires-Cre^* mice. We classified terminals as GABAergic or cholinergic by antibody staining against VGAT and VAChT, respectively ([Figure 5A](#fig5){ref-type="fig"}). Compared to array tomography, the thicker slices make it easier to follow individual axons with many putative pre-synaptic terminals. These data show that individual cortical VIP^+^/ChAT^+^ terminals have highly variable expression of VAChT ([Figure 5B--D](#fig5){ref-type="fig"}), with some axon stretches entirely lacking VAChT ([Figure 5B](#fig5){ref-type="fig"}), others being entirely positive for VAChT ([Figure 5C](#fig5){ref-type="fig"}), and some stretches presenting intermingled VAChT-containing and VAChT-lacking terminals ([Figure 5D](#fig5){ref-type="fig"}).

![Variable expression of VAChT in the presynaptic terminals of cortical ChAT^+^ neurons.\
(**A**) Example images of cortical ChAT^+^ pre-synaptic terminals labeled with AAV(8)-DIO-Synaptophysin-mCherry injected in the motor cortex of *Chat^ires-Cre^* mice. Left: Synaptophysin mCherry; Middle: VAChT immunostain; Right: VGAT immunostain. (**B--D**) Example images showing putative Synaptophysin-mCherry^+^ axons, with VAChT^-^ terminals (**B**), VAChT^+^ terminals (**C**), and intermingled terminals that are both VAChT^+^ and VAChT^-^. (**D**). (**E**) Histogram of mean VAChT fluorescence intensity within Synaptophysin-mCherry^+^ terminals. Black histogram represent the actual VAChT intensities, grey histogram represents the mean VAChT intensities when the mCherry image mask is rotated 90° relative to the VAChT immunostain image. (**F**) Scatter plot of mean VGAT intensity and VAChT intensity in each putative pre-synaptic terminals (n = 12,356 putative terminals from 30 image stacks from 3 *Chat^ires-Cre^* mice). Terminals are color-coded according to expression of VAChT and VGAT (Black -- neither VGAT or VAChT, Magenta -- both VGAT and VAChT, Cyan -- VAChT only, Yellow -- VGAT only). (**G**) Quantification of the number of terminals of each type in (**F**).](elife-57749-fig5){#fig5}

Quantification of VAChT intensity within VIP^+^/ChAT^+^ individual terminals shows a range of VAChT expression, including strongly labeled terminals and others whose labeling intensities overlap with negative control intensities, which were calculated by measuring the overlap of the pre-synaptic terminal image mask rotated 90 degrees with respect to the VAChT signal image ([Figure 5E](#fig5){ref-type="fig"}). Overall, VAChT and VGAT intensities positively correlated across terminals (R^2^ = 0.33, [Figure 5F](#fig5){ref-type="fig"}), though a population of VGAT-expressing terminals lacking VAChT were found. We categorized each terminal as positive or negative for each vesicular transporter according to a fluorescence intensity threshold that maximally separates VAChT or VGAT signal from the background of each image. By this classification, the majority of terminals are positive for both VGAT and VAChT ([Figure 5G](#fig5){ref-type="fig"}, R^2^ = 0.232), with a subset that are positive for VGAT but not VAChT ([Figure 5G](#fig5){ref-type="fig"}, R^2^ = 0.091). This held true across a range of classification thresholds. The likelihood that a terminal is VGAT^+^ increases monotonically as the threshold for VAChT is raised, while the proportion of VAChT^+^ terminals plateaus around 75% even at very high thresholds for VGAT ([Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). In other words, strong expression of VAChT ensures co-expression of VGAT, but many highly VGAT-expressing terminals lack VAChT. We also analyzed both VAChT and VGAT expression in pre-synaptic terminals across cortical layers, finding a small but significant decrease in VAChT^+^ and increase in VGAT^+^ terminals in layer 1 ([Figure 5---figure supplement 1C,D](#fig5s1){ref-type="fig"}). As an additional negative control, we repeated this analysis in *Sst^ires-Cre^* mice, and confirmed that terminals of Sst^+^ interneurons, which do not express *Slc18a3*, were almost completely negative for VAChT protein, with no relationship between VGAT and VAChT fluorescence intensity per terminal ([Figure 5---figure supplement 1E--I](#fig5s1){ref-type="fig"}). In summary, we identified two different populations of terminals, those capable of releasing both GABA and ACh and those capable of releasing only GABA. This suggests that release of ACh from these neurons is likely to be targeted to specific post-synaptic neurons.

A sparse population of non-VIP ChAT+ neurons specific to the mPFC {#s2-4}
-----------------------------------------------------------------

A recent publication reported rates of GABA and ACh connectivity from cortical ChAT^+^ neurons that were strikingly different from what we described above ([@bib35]). They reported that optogenetic activation of cortical ChAT^+^ neurons frequently resulted in postsynaptic cholinergic currents and rarely GABAergic currents. To reconcile these results with ours, we compared the experimental conditions in the two studies. In addition to differences in the composition of recording solution, a major difference between our studies is the choice of brain regions - their connectivity analysis was restricted to medial prefrontal cortex (mPFC), whereas the majority of our experiments were conducted in motor cortex (M1).

We first compared connectivity to layer 1 interneurons between mPFC and M1 from all forebrain cholinergic neurons using a mouse line that expressed ChR2 in all cholinergic neurons (*Chat^ires-Cre^* x *Rosa26^lsl-ChR2-EYFP,^* [Figure 6A](#fig6){ref-type="fig"}). To our surprise, we found significant differences in the proportion of cholinergic responses between M1 and mPFC, with more frequent cholinergic responses in the latter ([Figure 6B--D](#fig6){ref-type="fig"}), indicating a fundamental difference in cholinergic innervation of these two cortical regions. To determine if these differences could be explained by ACh release from local cortical cholinergic interneurons, we injected AAV-encoding Cre-dependent ChR2-mCherry directly to the mPFC and M1 in *Chat^ires-Cre^* mice and compared synaptic responses in layer 1 interneurons across brain regions ([Figure 6E](#fig6){ref-type="fig"}). We found a reduced rate of overall connectivity, most likely due to lack of ChR2 expression in basal forebrain projections to cortex and incomplete transduction of cortical ChAT^+^ neurons with AAV. Nevertheless, we observed that a significantly larger proportion of layer 1 neurons receives cholinergic input in the mPFC compared to in M1 (20/131 neurons with nAChR responses in mPFC compared to 1/43 in M1) and significantly fewer proportion of GABAergic responses (9/131 neurons with GABA~A~R responses compared to 13/43 in M1, [Figure 6F--H](#fig6){ref-type="fig"}). These results could not be explained by other major differences between our studies such as the brain slice cutting solution ([Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}) and the internal whole-cell recording solution ([Figure 6---figure supplement 1A,C](#fig6s1){ref-type="fig"}). Indeed, within the mPFC our results are consistent with those of Obermayer et al, and indicate a difference in the connectivity of local cholinergic neurons between the mPFC and motor cortex.

![Cholinergic connectivity to Layer 1 interneurons is greater in medial pre-frontal cortex than motor cortex, but not from VIP^+^ interneurons.\
(**A**) Experimental design: Acute coronal slices taken \~1.8 mm anterior to bregma were obtained from mice where all cholinergic neurons express ChR2 (*Chat^ires-Cre^* x *Rosa26^lsl-ChR2^*) and whole-cell voltage clamp recordings made from layer 1 interneurons in mPFC and M1. (**B**) Proportion of layer 1 interneurons showing nAChR-mediated and GABA~A~R-mediated synaptic responses, as determined by clamping the cell to −70 mV and 0 mV, respectively. (n = 47 total neurons from 5 *Chat^ires-Cre^* x *Rosa26^lsl-ChR2^* mice). (**C**) Example traces of GABA~A~R-mediated (top) and nAChR-mediated synaptic responses (bottom), as confirmed by block by gabazine and a cocktail of nAChR antagonists (DHβE, MLA, MEC). (**D**) Direct comparison of the proportion of cells showing nAChR-mediated responses (left, p=0.0007) or GABA~A~R-mediated responses (right, p=0.7431). (**E--H**) Same as (**A--D**), but only cortical ChAT^+^ neurons now express ChR2, through injection of Cre-dependent ChR2 virus to both M1 and mPFC (AAV(8)-DIO-ChR2-mCherry). Direct comparison of the proportion of cells with nAChR-mediated responses (bottom) shows a significant decrease in M1 compared to mPFC (left, p=0.0301), while those with GABA~A~R-mediated responses show a significant increase (right, p=0.0002; n = 174 total neurons from 9 *Chat^ires-Cre^* mice). (**I--L**) Same as (**A--C**) and (**E--G**), but for acute coronal slices with all VIP^+^ interneurons expressing ChR2 (*Vip^ires-Cre^* x *Rosa26^lsl-CHR2-EYFP^*). (n = 64 neurons from 7 *Vip^ires-Cre^* x *Rosa26^lsl-ChR2-EYFP^* mice). Example of the sole nAChR-mediated synaptic response obtained from a Layer 1 interneuron following optogenetic stimulation of VIP neurons is shown in (**K**). Direct comparison of the proportion of cells with nAChR- or GABA~A~R-mediated responses is not significantly different between mPFC and M1 (p=0.3906 and p=1, respectively). Single asterisk (\*) indicates significance at p\<0.05, triple asterisk (\*\*\*) indicates significance at p\<0.001 and all p-values calculated by Fisher's exact test.](elife-57749-fig6){#fig6}

To test whether this difference in connectivity across brain regions is specific to VIP^+^/ChAT^+^ neurons and to eliminate the possibility of contamination from long-range cholinergic axons, we repeated this experiment using mice that express ChR2 in all VIP^+^ interneurons (*Vip^ires-Cre^* x *Rosa26^lsl-ChR2-EYFP^*). We reasoned that because sub-cortical cholinergic neurons do not express *Vip* ([Figure 6---figure supplement 2A--C](#fig6s2){ref-type="fig"}), any cholinergic responses elicited by optogenetic stimulation of VIP^+^ interneurons would be attributable to local cortical VIP^+^/ChAT^+^ neurons ([Figure 6I](#fig6){ref-type="fig"}). However, we only identified a single cholinergic response in mPFC, with the majority of synaptic responses from VIP^+^ interneuron activation in mPFC and M1 being GABAergic ([Figure 6J--L](#fig6){ref-type="fig"}). In additional recordings, we included gabazine to block GABA~A~R-mediated responses and allow for more rapid screening of nAChR-mediated responses, but did not find additional nAChR-mediated responses ([Figure 6---figure supplement 2D,E](#fig6s2){ref-type="fig"}). We also screened for potential muscarinic ACh receptor responses from VIP^+^ interneurons throughout the cortex, with and without acetylcholine esterase inhibition to increase the size and duration of potential responses, but did not identify synaptic responses that we could confirm to be mediated by release of acetylcholine ([Figure 6---figure supplement 2F--J](#fig6s2){ref-type="fig"}). We tested the possibilities that VIP^+^ interneurons could be induced to be cholinergic in mice raised in a reverse light cycle ([Figure 6---figure supplement 3A,B](#fig6s3){ref-type="fig"}), in case the circadian cycle, which also differed between our study and that of Obermayer et al, caused changes in the ability of VIP^+^ interneurons to release ACh. We also tested exposure to isoflurane ([Figure 6---figure supplement 3A,C](#fig6s3){ref-type="fig"}), and viral delivery of ChR2 ([Figure 6---figure supplement 3D,E](#fig6s3){ref-type="fig"}), to rule out the possibility that the act of delivering virus, which is unnecessary when surveying connectivity from all VIP^+^ interneurons, induced a switch to more cholinergic signaling. However, none of these manipulations increased the rate of cholinergic synaptic responses. This relative lack of cholinergic responses from the wider population of VIP^+^ interneurons is more similar to the connectivity observed from cortical VIP^+^/ChAT^+^ neurons in the motor cortex.

If not arising from VIP-expressing ChAT^+^ interneurons, what is the local source of cholinergic inputs to layer 1 interneurons in mPFC? When performing our connectivity analysis in the mPFC, we noticed the presence of ChR2-EYFP^+^ neurons with strikingly different morphology than typical VIP^+^/ChAT^+^ interneurons, with larger cell bodies and an orientation parallel to the cortical surface ([Figure 7A](#fig7){ref-type="fig"}) instead of perpendicular ([Figure 1](#fig1){ref-type="fig"}). Fluorescent in situ hybridization for *Chat* and *Vip* revealed a sparse population of neurons in the mPFC that express high levels of *Chat* but not *Vip* mRNA ([Figure 7B](#fig7){ref-type="fig"}).

![Non-VIP ChAT^+^ neurons contribute to cholinergic connectivity in the mPFC.\
(**A**) Example images from a *Chat^ires-Cre^* x *Rosa26^lsl-CHR2-EYFP^* mouse. In the mPFC (red inset, left panel), two neurons are shown that are oriented parallel to the cortical surface, as opposed to the typical perpendicular orientation, (middle left panel, arrowheads) which have strong staining against ChAT (middle right panel, arrowheads). (**B**). Fluorescent in situ hybridization from mPFC reveals a sparse population of cells with strong labeling for *Chat*, but not for *Vip*. Approximate location of *Chat*-expressing, *Vip*-lacking neurons across 3 different mice are indicated by red dots, and the locations of three example images (right panels) shown by red boxes. Arrowheads indicate *Vip*-lacking, *Chat^+^* neurons, the asterisk in panel 3 indicates a nearby neuron expressing both *Vip* and *Chat*. (**C**) Cortical VIP^+^ neurons develop from the caudal ganglionic eminence (CGE), whereas PV^+^, Sst^+^, and most cholinergic neurons of the medial septum (MS) and basal forebrain (BF), derive from Nkx2.1-expressing neurons of the medial ganglionic eminence (MGE). Neurons genetically labeled by transient expression of Nkx2.1 and ChAT (*Chat^ires-Cre^* x *Nkx2.1^ires-FLP^* x RC::FLTG, middle left panel) exist in the mPFC that strongly label for ChAT protein (middle right panel) in adult mice. (**D**) Example Nkx2.1^+^/ChAT^+^ neuron (left panel) demonstrating a lack of colabeling with *Vip* (middle, right panels). (**E**) Experimental design: AAV(8)-DIO-ChR2-mCherry is injected directly into the mPFC and allowed to express for 3 weeks. Whole-cell voltage clamp recordings were then taken from layer 1 interneurons in the immediate vicinity of putative non-VIP ChAT^+^ neurons, as indicated by their morphology and large soma compared to VIP^+^ interneurons. (**F**) Summary of the proportion of layer 1 interneurons showing synaptic responses following optogenetic stimulation of nearby putative Non-VIP ChAT^+^ neurons. GABA~A~R- and nAChR-mediated synaptic responses are differentiated based on reversal potential and sensitivity to selective antagonists. Example nAChR-mediated synaptic response recorded at −70 mV in the presence of glutamatergic antagonists NBQX and CPP, blocked by nAChR antagonists DHβE, MLA, and MEC. No GABA~A~R-mediated synaptic responses were observed near putative Non-VIP ChAT^+^ neurons in the absence of other nearby VIP^+^/ChAT^+^ neurons. (n = 30 neurons from 6 *Chat^ires-Cre^* mice).](elife-57749-fig7){#fig7}

Because these neurons lacked *Vip* expression, we hypothesized that they derive from a different developmental origin than the VIP^+^/ChAT^+^ interneurons. VIP interneurons are derived from the caudal ganglionic eminence, whereas most sub-cortical cholinergic neurons develop from medial ganglionic eminence progenitors that are marked by transient expression of the transcription factor Nkx2.1 ([@bib28]; [@bib1]; [Figure 7C](#fig7){ref-type="fig"}). Indeed, using an intersectional genetic strategy ([@bib44]; [@bib18]) to label neurons that express, even transiently, both *Chat* and *Nkx2.1* (*Chat^ires-Cre^* x *Nkx2.1^ires-Flp^* x RC:FLTG), we identified Nkx2.1-lineage neurons in the mPFC that immunolabel for ChAT but not for VIP ([Figure 7C,D](#fig7){ref-type="fig"}). These neurons were exceptionally sparse - both non-VIP, ChAT^+^ neurons identified by FISH ([Figure 7B](#fig7){ref-type="fig"}) and Nkx2.1^+^/ChAT^+^ neurons identified genetically ([Figure 7C,D](#fig7){ref-type="fig"}), only 3--5 neurons were identifiable in each analyzed mouse brain, indicating that these are the same population of cells (see additional examples of morphology and orientation in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). We did not find any examples of genetically-labeled Nkx2.1^+^/ChAT^+^ neurons in other regions of the cortex in a whole-brain survey, suggesting that the low rate of non-VIP, ChAT^+^ neurons we report in [Figure 2A & B](#fig2){ref-type="fig"} is due to false negatives as a result of incomplete labeling and does not indicate the presence of Nkx2.1^+^/ChAT^+^ neurons outside of the mPFC. Given the existence of these non-VIP, ChAT^+^ neurons in the mPFC, we repeated our connectivity analysis as described above by injecting AAV-encoding Cre-dependent ChR2-mCherry into the mPFC of *Chat^ires-Cre^* mice. We focused only on potential post-synaptic layer 1 interneurons in the immediate vicinity of ChR2-expressing non-VIP ChAT^+^ neurons, identifiable by their unique morphology and relatively large soma. Indeed, layer 1 interneurons near ChR2-expressing non-VIP ChAT^+^ neurons (but without nearby VIP^+^/ChAT^+^ neurons) received nicotinic cholinergic following optogenetic stimulation, but not GABAergic synaptic currents ([Figure 7E](#fig7){ref-type="fig"}). Thus, we have identified a previously unknown MGE-derived population of non-VIP cholinergic neurons that explain the differential synaptic connectivity of local ChAT^+^ neurons between mPFC and other regions of cortex. Given that only a few of these neurons are present in any given mouse brain, and because they are not present outside of the mPFC, their absence from systematic surveys of cortical cell classes is not surprising.

Discussion {#s3}
==========

In this study, we characterized the synaptic physiology and anatomy of cortical ChAT^+^ interneurons, focusing primarily on the vast majority that are a subset of VIP^+^ interneurons. These VIP^+^/ChAT^+^ interneurons co-transmit both GABA and ACh, targeting each neurotransmitter onto different post-synaptic neurons. ACh transmission is sparse and primarily targets layer 1 interneurons and other VIP^+^/ChAT^+^ interneurons. In contrast, GABA transmission is widespread onto inhibitory interneuron subtypes, especially Sst^+^ interneurons, a pattern of GABAergic connectivity that is consistent with previous analyses of VIP^+^ cells ([@bib40]; [@bib19]). These functional results are complemented by imaging data showing pre-synaptic specialization of the ability of VIP^+^/ChAT^+^ neurons to release ACh and GABA. However, given the enrichment for ACh synthesis and release proteins in the pre-synaptic terminals and our finding that the majority of VIP^+^/ChAT^+^ synapses are competent to release both ACh and GABA, the relative sparsity of ACh-mediated responses remains surprising.

Given the low number of post-synaptic cholinergic responses we observed, there are several possibilities for the function and synaptic logic of ACh release. One possibility is that these neurons release ACh onto a distinct post-synaptic target we have not identified molecularly. Although we attempted to be as comprehensive as possible in surveying potential post-synaptic targets, the full diversity of cortical cellular subtypes is only beginning to be understood, and it is therefore possible that future research will identify a neuronal subtype that is strongly innervated by ACh released from VIP^+^/ChAT^+^ synapses. Similarly, ACh released by VIP^+^/ChAT^+^ interneurons may have primarily metabotropic effects, including generative post-synaptic effects that we are unable to detect electrophysiologically. We searched extensively for post-synaptic responses mediated by muscarinic ACh receptors without success ([Figure 6---figure supplement 2D--H](#fig6s2){ref-type="fig"}), but we did not examine potential changes in cellular excitability or synaptic plasticity. Another possibility is that ACh transmission is indeed very sparse, but highly targeted, activating specific subnetworks of disinhibitory interneurons. This possibility is consistent with previous studies showing that the firing of VIP^+^ interneurons can recruit other VIP^+^ interneurons via nAChRs ([@bib20]). Finally, ACh transmission from VIP^+/^ChAT^+^ neurons may be conditional such that it only occurs in certain contexts or developmental epochs. Precedent for this has been observed following critical period plasticity in the visual and auditory cortex, when increased expression of Lynx1 blocks nAChR-mediated signaling to limit synaptic plasticity, and deletion of Lynx1 can reveal previously masked nAChR-mediated currents ([@bib33]; [@bib61]) Regulation of neurotransmitter release has also been observed in other systems, such as the retina where ACh and GABA are differentially released by starburst amacrine cells depending on the direction of the light stimulus ([@bib25]; [@bib54]), and in several examples where neurons appear to switch their predominant neurotransmitter during development or after bouts of neuronal activity ([@bib57]).

Nevertheless, the pattern of GABA and ACh connectivity we describe suggests a coherent model of the net effect that these neurons have on cortical circuits: ACh-mediated excitation of other layer 1 and VIP^+^/ChAT^+^ disinhibitory interneurons, combined with the GABA-mediated disinhibition, provides a powerful activating signal to local cortical areas. This is consistent with previous findings showing that VIP^+^ interneurons can promote the cooperative firing of other VIP^+^ interneurons partially through activation of nAChRs ([@bib20]). In different behavioral paradigms, activation of VIP^+^ and layer 1 interneurons has been shown to increase the gain of sensory responses in pyramidal neurons ([@bib41]; [@bib14]) or signal a cue for fear conditioning ([@bib27]). In each of these cases, these disinhibitory neurons are activated by ascending cholinergic inputs from basal forebrain. We propose that ACh release reinforces and amplifies the cortical activation achieved by the broader VIP^+^ interneuron population, itself activated by ascending cholinergic projections, in order to enhance the response to salient cues. Cortical ChAT^+^ neurons in barrel cortex are strongly activated by sensory stimuli, supporting this model, but optogenetic activation of cortical ChAT^+^ neurons actually slightly decreases the response of other neurons to whisker deflections ([@bib11]), suggesting additional complexities. One explanation is that strong optogenetic activation may occlude the time-locked, stimulus-evoked firing of cortical ChAT^+^ neurons, decreasing their ability to boost neuronal activity. Further experiments are necessary to clarify the in vivo functional role of cortical ChAT^+^ neurons on cortical processing.

The synaptic connectivity of VIP^+^/ChAT^+^ interneurons illustrates several notable modes of synaptic transmission. First, they are a local source of ACh that is sparse and highly targeted, contrasting with the broadly dispersed, long-range projections from the basal forebrain. This raises the possibility of neuromodulation by ACh that occurs within highly specific subnetworks of cortical neurons, as opposed to a bulk signal that affects large regions of cortex at once. This is consistent with a recent reevaluation of cortical ACh signaling as not only a diffuse, tonic signal that operates on relatively slow time scales, but also as a phasic signal that operates on the time scale of seconds and milliseconds ([@bib49]).

Second, they provide an example of specialized pre-synaptic terminals that allow for targeting of different neurotransmitters to specific outputs. Such output-specific targeting of neurotransmitter release is a largely unexplored aspect of synaptic transmission in the brain. Our data are consistent with two different models of output-specific targeting -- either multiple subtypes of VIP^+^/ChAT^+^ interneurons differentially release ACh, or individual VIP^+^/ChAT^+^ interneurons with specialized presynaptic terminals that target different neurotransmitters to specific outputs. Given our observation of individual stretches of axon with intermingled VAChT^+^ and VAChT^-^ terminals ([Figure 5D](#fig5){ref-type="fig"}, we favor the model of individual VIP^+^/ChAT^+^ neurons that tailor their neurotransmitter output based on the target neuron. A similar level of regulation can be observed in dopaminergic neurons which spatially segregate co-release of glutamate and dopamine in different brain regions ([@bib58]; [@bib32]), and whose individual axons segregate terminals that release dopamine or glutamate ([@bib69]). Similar differentiation of neurotransmitter release has been reported elsewhere in the cholinergic system, specifically in Globus Pallidus externus projections to the cortex ([@bib51]) and in hippocampus-projecting septal cholinergic neurons that release ACh and GABA from different synaptic vesicles ([@bib60]). The possibility for separable release of multiple neurotransmitters adds another level of complexity to our understanding of how neurons communicate.

Third, our study identifies a multiple levels of heterogeneity within cortical ChAT^+^ neurons. The first is existence of multiple subtypes of cortical ChAT^+^ neurons that differ in developmental origins, molecular profiles, and synaptic connectivity. Whereas the vast majority of cortical ChAT^+^ neurons are a subset of VIP^+^ interneurons, which are CGE-derived, we discovered a small population (only several neurons present in each mouse brain) of non-VIP ChAT^+^ neurons derived from Nkx2.1-expressing (MGE and pre-optic area derived) progenitors that are developmentally more similar to cholinergic neurons of the basal forebrain ([@bib28]; [@bib1]). Notably, within cortex these non-VIP ChAT^+^ neurons are found only mPFC, potentially why they are not identifiable in recently published single-cell RNA sequencing data sets ([@bib52]; [@bib62]; [@bib68]) and have evaded widespread notice.

The presence of non-VIP ChAT^+^ neurons explains the differences in connectivity between our study and a recent one that examind cortical ChAT^+^ interneuron connectivity in the mPFCanderroneously attributed all local cholinergic connectivity to VIP^+^/ChAT^+^ neurons ([@bib35]). Another major difference between our two studies is that our experiments were conducted entirely in mice, whereas they made extensive use of ChAT-Cre transgenic rats (although reached the same conclusions from their more limited analysis of mice). Rats may have a greater proportion of ChAT^+^, VIP^+^ interneurons, raising the possibility that ACh transmission is more prevalent from cortical VIP^+^/ChAT^+^ neurons in rat than in mice.

We find that further heterogeneity exists within VIP^+^/ChAT^+^ interneurons and their pre-synaptic terminals. We observed two separate terminal populations, one capable of releasing both ACh and GABA, and another capable of releasing only GABA. The presence of stretches of axons with only one class of presynaptic bouton suggests that this heterogeneity exists within axons of single VIP^+^/ChAT^+^ neurons or that there are two subpopulations of VIP^+^/ChAT^+^ neurons. In either case, individual VIP^+^/ChAT^+^ neurons have specialized pre-synaptic terminals that differentially target GABA and ACh onto post-synaptic neurons.

The existence of cortical ChAT^+^ neurons requires a reevaluation of studies that globally manipulate cholinergic signaling in cortex. While many studies specifically targeted cortically-projecting basal forebrain neurons, several have used genetic crosses that affect all cholinergic neurons in the brain ([@bib8]; [@bib56]; [@bib24]; [@bib10]), and therefore include confounding effects from local VIP^+^/ChAT^+^ interneurons. Studies that use ChAT-BAC-ChR2 mice to activate cholinergic neurons not only run the risk of confounding gain-of-function effects due to overexpressed VAChT ([@bib22]), but also from incidental manipulation of cortical VIP^+^ interneurons, which are known to have profound effects on cortical function even purely through GABA release. Going forward, studies of cholinergic signaling in cortex must differentiate between contributions from basal forebrain projections and those from local cholinergic interneurons.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                Designation                                Source or\                      Identifiers                                              Additional\
  (species) or\                                                                           reference                                                                                information
  resource                                                                                                                                                                         
  -------------------------------------------- ------------------------------------------ ------------------------------- -------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (*Mus musculus*)   Wild-type                                  Jackson Labs                    C57BL6/J                                                 Stock\#00664

  Strain, strain background (*Mus musculus*)   *Chat^ires-Cre^*                           Jackson Labs                    B6;129S6- *Chat^tm1(cre)Lowl^*/J                         Stock \# 006410

  Strain, strain background (*Mus musculus*)   *Vip^ires-Cre^*                            Jackson Labs                    VIP^tm1(cre)Zjh^/J                                       Stock \# 010908

  Strain, strain background (*Mus musculus*)   *Sst^ires-Flp^*                            Jackson Labs                    Sst^tm3.1(flpo)Zjh^/J                                    Stock \# 028579

  Strain, strain background (*Mus musculus*)   *Rosa26^lsl-tdTomato^*, (Ai14)             Jackson Labs                    B6.129Sg-Gt(ROSA)26Sor^tm14(CAG-tdTomato)Hze^/J          Stock \# 007908

  Strain, strain background (*Mus musculus*)   *Rosa26^lsl-ChR2-EYFP^*, (Ai32)            Jackson Labs                    B6;129S-Gt(ROSA)26Sor^tm32(CAG-COP4\*H134R/EYFP)Hze^/J   Stock \# 012569

  Strain, strain background (*Mus musculus*)   Sst-GFP (GIN)                              Jackson Labs                    FVB-Tg(GadGFP)45704Swn/J                                 Stock \# 003718, referred to as \"GIN\" mice by the Jackson Laboratory, as \"Sst-GFP\" mice in the text.

  Strain, strain background (*Mus musculus*)   PV-GFP (G42)                               Jackson Labs                    CB6-Tg(GAD1-EGFP)G42zjh/J                                Stock \# 007677, referred to as \"GAD67-GFP\" or \"G42 line\" mice by the Jackson laboratory, as \"PV-GFP\" mice in the text.

  Strain, strain background (*Mus musculus*)   5HT3aR-GFP                                 Gift from B. Rudy lab (NYU)     Tg(Htr3a-EGFP)DH30Gsat                                   

  Strain, strain background (*Mus musculus*)   *Gad2^ires-GFP^*                           Jackson Labs                    Gad2^tm2(cre)Zjh)^/J                                     Stock \# 010802

  Strain, strain background (*Mus musculus*)   *Slc18a3^fl^*^/fl^                         Gift of V. and M. Prado (UWO)   VAChT^flox/flox^                                         [@bib29]

  Strain, strain background (*Mus musculus*)   *Slc32a1^fl^*^/fl^                         Jackson Labs                    Slc32a1^tm1Lowl^/J                                       Stock \# 012897

  Strain, strain background (*Mus musculus*)   *Nkx2*.1^ires-Flp^                         Jackson Labs                    Nkx2-1^tm2.1(flop)Zjh^                                   Stock \# 028577

  Strain, strain background (*Mus musculus*)   RC::FLTG                                   Jackson Labs                    B6.Cg-Gt(ROSA)26Sor^Tm1.3(CAG-tdTomato,-EGFP)Pjen^/J     Stock \#026932

  Strain, strain background (AAV)              AAV(8)-EF1ɑ-hChR2(H134R)-mCherry-WPRE-pA   UNC Vector Core                                                                          Titer:\~2×10^13^ gc/ml

  Strain, strain background (AAV)              AAV(DJ)-EF1ɑ-fDIO-EYFP                     BCH Viral Core                                                                           Titer:\~2×10^12^ gc/ml

  Strain, strain background (AAV)              AAV(1)- EF1ɑ-fDIO-ChR2-EYFP                BCH Viral Core                                                                           Titer:\~5×10^13^ gc/ml

  Strain, strain background (AAV)              AAV(8)- EF1ɑ-DIO-FlpO                      BCH Viral Core                                                                           Titer:\~7×10^11^ gc/ml

  Strain, strain background (AAV)              AAV(8)- EF1ɑ-DIO-mCherry                   UNC Vector Core                                                                          Titer:\~6×10^12^ gc/ml

  Strain, strain background (AAV)              AAV(8)-CMV-DIO-Synaptophysin-EYFP          UNC Vector Core                                                                          Titer:\~6×10^12^ gc/ml

  Strain, strain background (AAV)              AAV(9)-CAG-DIO-Synaptophysin-mCherry       MIT McGovern Viral Core                                                                  Titer:\~2×10^13^ gc/ml

  Antibody                                     chicken ɑ-GFP                              GeneTex                         GTC13970                                                 Dilution: 1:500

  Antibody                                     mouse ɑ-Gephyrin                           Biosciences Parmingen           612632                                                   Dilution: 1:500

  Antibody                                     rabbit ɑ-Synapsin-1                        Cell Signaling Technology       5297S                                                    Dilution: 1:500

  Antibody                                     rabbit ɑ-PSD95                             Cell Signaling Technology       3450                                                     Dilution: 1:500

  Antibody                                     rabbit ɑ-VGAT                              Synaptic Systems                131 011                                                  Dilution: 1:500

  Antibody                                     mouse ɑ-VAChT                              Synaptic Systems                139 103                                                  Dilution: 1:500

  Antibody                                     guinea pig ɑ-VGAT                          Millipore                       AB5905                                                   Dilution: 1:500

  Antibody                                     goat ɑ-ChAT                                Millipore                       AB144P                                                   Dilution: 1:500;

  Antibody                                     Rabbit ɑ-VIP                               ImmunoStar                      20077                                                    Dilution: 1:500

  Antibody                                     Rabbit ɑ-Somatostatin, Clone YC7           Millipore                       MAB354                                                   Dilution: 1:500

  Antibody                                     mouse ɑ-Parvalbumin                        Millipore                       MAB1572                                                  Dilution: 1:500

  Sequence-based reagent                       Mm-Chat-C2                                 ACDBio                          408731-C2                                                

  Sequence-based reagent                       Mm-Slc32a1                                 ACDBio                          319191                                                   

  Sequence-based reagent                       Mm-Gad1-C3                                 ACDBio                          400951-C3                                                
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Mice {#s4-1}
----

All mice used in this study were between 2 and 4 months in age. For experiments using only *Chat^ires^*^-Cre^ mice, homozygous mice were maintained. For all crosses of two or more mouse lines, homozygous breeders were used to produce heterozygous off-spring for experiments, with the exception of experiments requiring conditional deletion of VGAT or VAChT, in which case homozygous *Slc32a1*^fl/fl^ or *Slc18a3*^fl/fl^ conditional knock-out mice were produced that were either homozygous or heterozygous for *Chat^ires^*^-Cre^ or *Vip^ires^*^-Cre^, respectively. All mice were maintained in a 12 hr light-dark cycle, with the light cycle occurring between 7 am and 7 pm, with the exception of a cohort of mice in [Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}, which lived in a reverse 12 hr light cycle. All experiments were performed according to animal care and use protocols approved by the Harvard Standing Committee on Animal Care in compliance with guidelines set for in the NIH *Guide for the Care and Use of Laboratory Animals*.

Virus injections {#s4-2}
----------------

For intracranial injection of virus, the surgery work area was maintained in aseptic conditions. Mice were anesthetized with 2--3% isoflurane and given 5 mg/kg ketoprofen as prophylactic analgesic, and placed on a heating pad in a stereotaxic frame (David Kopf Instruments) with continuous delivery and monitoring of appropriate isoflurane anesthesia. For one set of experiments ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}), a cohort of mice were put under isoflurane anesthesia for two hours and allowed to recover without subsequent surgery. For the surgery, the skin above the skull was carefully cleared of hair with scissors and depilatory cream (Nair) and sterilized with alternating scrubs with alcohol pads and betadine pads. A midline incision was made in the skin and the skull exposed and small holes drilled into the skull at the appropriate coordinates depending on the injection site. For injections into motor cortex, injection coordinates were (relative to bregma):±1.8 mm ML, + 1.8 mm and + 0.5 mm AP, and −0.6 mm from the pia. Visual cortex was targeted by injecting (from lambda):±2.5 mm ML, 0 mm AP, −0.25 mm from the pia. 200--500 nl of the appropriate virus was injected through a pulled glass pipette at a rate of 100 nl/min with a UMP3 microsyringe pump (World Precision Instruments) for each of these injection sites. For targeting medial prefrontal cortex, injection coordinates were (from bregma):±0.4 mm ML, + 1.8 mm AP, and −2.0 and −1.3 mm from pia. 250 nl of virus was injected at each of the mPFC sites as above. Following injection, the pipette was allowed to sit for 10 min to prevent leak of the virus from the injection site, and then the glass pipette slowly removed over the course of 1--2 min. Following surgery, mice were monitored in their home cage for 4 days following surgery, and received daily analgesia for 2 days following surgery. Mice were sacrificed for experiments at least 3 weeks following injection to allow for robust viral expression. When we injected multiple viruses, they were mixed in equal proportions.

Electrophysiology {#s4-3}
-----------------

300 µm acute coronal brain slices were prepared from mice deeply anesthetized with isoflurane inhalation and perfused with ice-cold cutting solution containing (in mM): 25 NaHCO~3~, 25 Glucose, 1.25 NaH~2~PO~4~, 7 MgCl~2~, 2.5 KCl, 0.5 CaCl2, 11.6 ascorbic acid, 3.1 pyruvic acid, 110 Choline chloride. Following dissection, brains were blocked by cutting along the mid-sagittal axis, and brains glued to the platform along the mid-sagittal surface before slicing on a Leica VT1000s vibratome, while maintaining submersion in cold choline cut solution. Following cutting, slices recovered for 30--45 min in 34° C artificial cerebral spinal fluid (aCSF) containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH~2~PO~4~, 25 NaHCO~3~, 11 glucose, 2 CaCl~2~, 1 MgCl~2~. Subsequently all recording took place in continuous perfusion (2--3 ml/min) of room temperature aCSF. Both the choline cut solution and aCSF were continuously equilibrated by bubbling with 95%--0~2~/5% CO~2~.

After recovery, slices were transferred to a recording chamber mounted on an upright microscope (Olympus BX51WI). Cells were imaged using infrared-differential interference contrast with a 40x water-immersion Olympus objective. To confirm ChR2 expression and GFP-labeled interneurons, we used epifluorescence with an X-Cite 120Q (Excelitas) as a light source. Whole cell voltage-clamp and current clamp recordings were obtained by forming intracellular seals with target neurons with patch pipettes pulled from borosilicate glass (BF150-86-7.5, Sutter). Pipettes (2--4 MOhm pipette resistance) were pulled with a P-97 flaming micropipette puller (Sutter). Pipettes were filled with either a Cs^+^-based internal recording solution containing (in mM): 135 CsMeSO~3~ 10 HEPES, 1 EGTA, 4 Mg-ATP, 0.3 Na-GTP, 8 Na~2~-Phosphocreatine, 3.3 QX-314 (Cl- salt), pH adjusted to 7.3 with CsOH and diluted to 290--295 mOsm/kg for voltage clamp recordings or a K^+^-based internal recording solution containing (in mM): 120 KMeSO~3~, 10 HEPES, 0.2 EGTA, 8 NaCL, 10 KCL, 4 Mg-ATP, 0.3 Na-GTP, pH adjusted to 7.3 with CsOH and diluted to 290--295 mOsm/kg for current clamp recordings.

To stimulate ChR2-expressing neurons, we focused a fiber-coupled 200 mW 473 nm laser (Opto-engine) onto the back aperture of 40x Olympus objected in the imaging path. Laser intensity was adjusted using a neutral density filter such that \~ 9 mW/mm^2^ of total light reached the slice. ChR2^+^ cells were regularly patched to confirm that laser intensity was well above the threshold needed to elicit action potentials at low latency (data not shown). Cells were classified as having a synaptic response based on the average of at least 10 individual sweeps of optogenetic stimulation. If a consistent, time-locked response above the baseline noise could be observed, additional sweeps were taken to get a more accurate representation of the response size and kinetics. Putative GABA-mediated currents were isolated by voltage clamping at 0 mV, the reversal potential for excitatory currents, or identified in current clamp as hyperpolarizing potentials that are blocked by 10 µM Gabazine (SR-95531, Tocris). Putative ACh-mediated currents were isolated by voltage clamping at −70 mV, the reversal potential for inhibitory currents, or in current clamp as depolarizing potentials, and confirmed with 10 µM Methyllycaconitine citrate (MLA, Tocris), which is selective for alpha7-containing nicotinic receptors, 10 µM Dihydro-beta-erythroidine hydrobromide (DHBE, Tocris), which is selective for alpha4-containing nicotinic receptors, and 10 µM Mecamylamine hydrochloride (MEC, Tocris), which is a non-selective nicotinic receptor antagonist. To confirm monosynaptic release of GABA, we consecutively added 1 µM TTX (Abcam) followed by 100 µM 4-aminopyridine (Tocris). To rule out contributions from other low latency excitatory receptors, we also added the glutamate receptor antagonists NBQX and CPP (both 10 µM, Tocris). For current-clamp recordings with putative muscarinic receptor-mediated currents, we washed on 10 µM Scopolamine hydrobromide (Tocris), and in a subset of experiments we included 10 µM GCP.-35348 (Tocris) to block GABA~B~ receptors and 10 µM physostigmine (Tocris) to inhibit ACh esterase.

Voltage clamp and current clamp recordings were amplified and filtered at 3 kHz using a Multiclamp 200B (Axon Instruments) and digitized at 10 kHz with a National Instruments acquisition boards. Data was saved with a custom version of ScanImage written in Matlab (Mathworks; <https://github.com/bernardosabatinilab/SabalabSoftware_Nov2009>). Additional off-line analysis was performed using Igor Pro (Wavemetrics). Response amplitudes were determined by averaging 5--10 traces, taking a 990 ms baseline prior to stimulation, and subtracting that from the peak amplitude within 5--20 ms after stimulation.

Fluorescent In situ hybridization {#s4-4}
---------------------------------

Whole brains dissected from deeply anesthetized wild-type C57/BL6 mice were fresh frozen in Tissue-tek OCT media on dry ice and stored at −80°C before being sliced into 20 µm slices on a CM 1950 Cryostat (Leica), mounted on SuperFrost Plus 25 × 75 mm slides (VWR), and stored at −80°C prior to labeling. Fluorescent in situ hybridization labeling was performed according to the RNAscope Fluorescent Multiplex Assay protocol (ACDBio).

Immunohistochemistry {#s4-5}
--------------------

Tissue was obtained from deeply anesthetized mice that were perfused transcardially with room temperature phosphate-buffered saline (PBS) followed by 4% paraformaldehyde (PFA) in PBS. The brain was then dissected out of the skull, post-fixed overnight at 4°C in 4% PFA, rinsed and stored in PBS. Brains were sliced into either 50 µm (for most figures) or 25 µm slices (for [Figure 6](#fig6){ref-type="fig"}) on a Leica VT1000s vibratome and stored in 24-well plates.

For staining, slices were first incubated in blocking buffer (10% Normal Goat Serum, 0.25% Triton-X in PBS, except 10% Normal Horse Serum for ChAT immunostaining) for 1 hr at room temperature on a rotary shaker, then placed in primary antibody solution (1:500 for each primary antibody diluted into carrier solution (10% Normal Goat Serum, 0.2% Triton-X in PBS) and left to shake overnight at 4°C. Slices were then washed 5--6 x in PBS, and placed into secondary antibody solution (1:500 in carrier solution) for 2 hr at room temperature. Slices were again washed, placed on glass slides, and mounted in Prolong Gold antifade mounting media with DAPI (Invitrogen).

Imaging and analysis {#s4-6}
--------------------

Immunostained and FISH samples were imaged on a VS120 slide scanner at 10x. Regions of interest were then imaged on either a FV1200 confocal microscope (Olympus) or a TCS SP8 confocal microscope (Leica) for colocalization analysis.

Immunostained samples were manually scored to count co-labeled cells using the Cell Counter plugin in Fiji (<https://fiji.sc/>). FISH samples were analyzed with an automated analysis pipeline custom written using Fiji and Matlab. A cellular mask was created by combining the 3 FISH channels and using the Renyi entropy thresholding algorithm to binarize the image. Each individual cell was identified, and the percent coverage of each FISH channel was calculated for each cell. A threshold to classify each cell as positive or negative for each FISH channel was then determined by selecting a threshold for percent coverage above ten manually-drawn background areas. From this analysis, we determined the proportion of cells that are positive for each of the different FISH probes.

Immunostained samples from [Figure 6](#fig6){ref-type="fig"} were imaged using the TCS SP8 confocal microscope (Leica) such that each acquisition utilized the full dynamic imaging range. For analysis, putative individual pre-synaptic terminals were identified by thresholding the raw image stacks of the Synaptophysin-mCherry signal, then filtering putative terminals for size and enforcing that they must be present across multiple images. Mean fluorescence intensity for VGAT and VAChT antibody staining was calculated for each putative terminal. Individual terminals were classified as VGAT or VAChT positive by automatically determining a threshold for VGAT/VAChT positive pixels using the Otsu method (which determines the intensity threshold that minimizes intraclass variance and maximizes interclass variance), and requiring that the terminal is positive or negative if the mean intensity is greater than or equal to the Otsu threshold.

Array tomography {#s4-7}
----------------

Brains from mice injected with AAV(8)-CMV-DIO-Synaptophysin-YFP were perfused, dissected, and fixed as for immunohistochemistry. 300 µm thick slices were then cut with a Lieca VT1000s vibratome. Areas of high Synaptophysin-YFP expression were noted using an epifluorescence microscope, and approximately 1 × 1 mm squares of tissue were cut out under a dissecting scope with Microfeather disposable ophthalmic scalpels. These small tissue squares were then dehydrated with serial alcohol dilutions and infiltrated with LR White acrylic resin (Sigma Aldrich L9774), and placed in a gel-cap filled with LR White to polymerize overnight at 50°C. Blocks of tissue were sliced on an ultramicrotome (Leica EM UC7) into ribbons of 70 nm sections.

Antibody staining of these sections was performed as previously described ([@bib51]). Briefly, antibodies were stained across multiple staining sessions, with up to three antibodies stained per session, and a fourth channel left for DAPI. Typically, Session 1 stained against YFP (chicken ɑ-GFP, GTX13970, GeneTex), Gephyrin (mouse ɑ-Gephyrin, 612632, Biosciences Pharmingen), and Synapsin-1 (rabbit ɑ-Synapsin-1, 5297S, Cell Signaling Tech), Session 2 for PSD-95 (rabbit ɑ-PSD95, 3450 Cell Signaling Tech.), Session 3 for VGAT (rabbit ɑ-VGAT, 131 011 Synaptic Systems), Session 4 for VAChT (mouse ɑ-VAChT, 139 103 Synaptic Systems) and VGLUT1 (guinea pig ɑ-VGAT, AB5905 Millipore), and Session 5 for ChAT (goat ɑ-ChAT, AB144P Millipore). One test sample was performed where the staining order was reversed, and while staining quality did appear degraded for later samples, it was not significant enough to alter analysis. Each round of staining was imaged on a Zeiss Axio Imager upright fluorescence microscope before the tissue ribbons were stripped of antibody and re-stained for a new session of imaging. Four images were acquired with a 63x oil objective (Zeiss) and stitched into a single final image (Mosaix, Axiovision). Image stacks were processed by first aligning in Fiji with the MultiStackReg plug-in, first on the DAPI nuclear stain, with fine alignments performed using the Synapsin 1 stack. Fluorescence intensity was also normalized across all channels, such that the top and bottom 0.1% of fluorescence intensities were set to 0 and maximum intensity, respectively.

For analysis, Synaptophysin-YFP masks were created by first masking out the edges of the images that did not contain any tissue sample and the DAPI signal to exclude cell nuclei, then by empirically determining an appropriate threshold of YFP fluorescence. Putative pre-synaptic terminals were required to exist on multiple z-places of the image stack, thus creating 3D binary masks corresponding to putative pre-synaptic terminals. Global cross-correlations were made by z-scoring the fluorescence signals of each antibody stack making pairwise comparisons among all stacks, shifting the images +/- 10 pixels vertically and horizontally and calculating the 2D co-variance at every shift. We interpreted correlations with DAPI as a proxy measure for the specificity of each pre-synaptic antibody, as these antibodies should completely avoid cell nuclei. In general the antibodies for synaptic markers were excluded from cell nuclei, although VGLUT1, VGAT, ChAT, and VAChT did show small positive correlations with DAPI ([Figure 4D](#fig4){ref-type="fig"}). Across pairs of pre-synaptic markers, the strongest cross-correlations occurred between Synapsin-1, PSD-95, and VGLUT1, reflecting both the high density of excitatory synapses and relatively low background signal with these antibodies. To specifically analyze co-variance of antibodies within the pre-synaptic terminals, we repeated the calculation of 2D covariance described above, but limited to the area of the images covered by VCIN-expressed Synaptophysin-YFP (\~0.1% of the total). Thus the co-expression of synaptic markers within these terminals contributes minimally to the global cross-correlations reported above. To avoid amplifying any small background signals that would result if an antibody signal was low in the YFP^+^ pre-synaptic terminals, we z-scored the fluorescence intensities across the entire image stack (as for the global cross correlation analysis above) but calculated the co-variance across signal pairs only within the YFP^+^ terminals.

Colocalization analysis was carried out using the same YFP mask as described above. Synaptic antibody signals were assigned to individual pixels by fitting each antibody punctum with a Gaussian distribution, and assigning the pixel corresponding to the peak of that Gaussian as the location of that antibody. Colocalization was then calculated by dividing the number of antibody pixels that overlapped with the YFP mask by the total number of pixels in the YFP mask. Similar colocalization values were also calculated within expanding single-pixel concentric volumes around each terminal, to compare the antibody colocalization within terminals with the immediately surrounding tissue. Finally, the location of each antibody puncta was randomized 1000 times, avoiding the DAPI masks, and the colocalization within and around the YFP terminals recalculated for each round of randomization. To compare across samples, this colocalization measure was converted to a z-score by subtracting the mean of the randomized data from the actual colocalization, divided by the standard deviation of the randomized data.

Blood vessel imaging {#s4-8}
--------------------

For surgical implantation of cranial windows, mice were anesthetized with 2--3% isoflurane, given 10 mg/kg ketoprofen as prophylactic analgesic, and 0.3 mg/kg Dexamethasone to limit tissue inflammation. Mice were placed on a heating pad in a stereotaxic frame (David Kopf Instruments) with continuous delivery and monitoring of appropriate isoflurane anesthesia. The skin above the skull was carefully cleared of hair with scissors and depilatory cream (Nair) and sterilized with alternating scrubs with alcohol pads and betadine pads. A midline incision was made in the skin and the skull exposed. A circular,\~3 mm diameter section of skull was carefully drilled from over the right barrel cortex, with frequent application of sterile saline. A cranial window, prepared by adhering a 3 mm glass coverslip to a 4 mm coverslip with optical glue, was placed over the brain, and secured in place with Kwik-cast silicone elastomer sealant (World Precision Instruments), followed by C and B-Metabond (Parkell) with a custom-made titanium head post. Following surgery, mice were monitored in their home cage for 4 days following surgery, and received daily analgesia for 2 days following surgery.

Alexa Fluor 633 hydrazide (5 mg•kg^−1^) was retro-orbitally injected into mice to visualize arterioles in vivo. Arterioles were imaged at 800 nm with a field of view size of 200 µm x 200 µm (512 × 512 pixels, pixel size of 0.16 µm^2^/pixel) at 30 Hz. Optical stimulation was performed using pulsed illumination (5 pulses, 20 Hz, 5 ms ON/45 ms OFF, 30 mW/mm2) using a 473 nm solid-state laser. Whisker stimulation (4 Hz, 5 s) was performed using a foam brush controlled by a servo motor under the control of Wavesurfer. Three technical trials where acquired and averaged for each field of view. 10--13 fields of view were acquired per imaging session. Three imaging sessions were collected on three separate days per mouse and arteriolar dilation responses were averaged across all three sessions for each mouse.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This paper combines anatomical and functional approaches to show that interneurons in the neocortex target two neurotransmitters to different sets of cellular targets. In addition, they show that cortical areas contain different subtypes of these interneurons. These results suggest additional mechanisms by which local interneurons regulate the patterns of neuronal activity in the neocortex in a cell-type and region-specific manner.

**Decision letter after peer review:**

Thank you for submitting your article \"Cortical ChAT^+^ neurons co-transmit acetylcholine and GABA in a target-and brain-region specific manner\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kenton Swartz as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Chris J McBain (Reviewer \#2); Steven Shabel (Reviewer \#3).

The reviewers have discussed the reviews with one another, and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in *eLife* but that some conclusions require additional analyses of the data, as they do with your article, we are asking that the manuscript be revised to preferably include these additional analyses or, when that is not possible under the current conditions, to either limit claims to those supported by data in hand or to explicitly state that the relevant conclusions require additional supporting data.

In this article, Granger et al. use optogenetic stimulation to examine the functional connectivity of VIP^+^/ChAT^+^ cortical interneurons in brain slices. Surprisingly, despite extensive expression of cholinergic markers in presynaptic cortical terminals, they observe few fast, cholinergic responses across cortical layers and cell types in primary motor cortex (M1). In contrast, they find widespread GABAergic transmission (predominantly in SOM^+^ interneurons), consistent with the expression of GABAergic markers in VIP^+^/ChAT^+^ neurons. Although few cells show clear ACh only transmission, the authors confirm using array tomography that presynaptic axon terminals can segregate ACh and GABA content, showing that release of ACh or GABA may be regulated between distinct downstream targets. To complement their studies in M1, the authors tackle the previous observation of ACh release from ChAT^+^ neurons in prefrontal cortex (PFC), data which would argue against their primary observation in motor cortex. They show evidence for a rare, VIP-/ChAT^+^ interneuron found in mPFC but not M1 and provide data implicating these in the more commonly detected ACh responses seen in PFC, highlighting circuit distinctions between these two cortical regions.

Revisions expected for this paper:

Overall, all three reviewers agreed that the experiments were well designed and well executed. One major concern related to the lack of explicit comparisons between M1 and PFC in some experiments (like the array tomography experiments) and clarifying the laminar and areal locations of other experiments as these areal and laminar differences are presented as major findings of the paper. Additional analyses explicitly comparing array tomography images between M1 and PFC and from layer 1 and other layers (laminar distribution) would significantly strengthen the manuscript. Furthermore, reporting, for example, the layer breakdown of the recordings from inhibitory neurons in Figure 3G and the layer and areal locations of the data analyzed in Figures 4 and 5 would improve the manuscript. Reporting the data for M1 and PFC separately in Figure 6J and indicating how many neurons were recorded in both regions would also contribute to these comparisons. A second major concern was that some experiments lacked quantification or explicit descriptions of the quantification. For example, additional quantification such as reporting the proportion of ChAT^+^ neurons that are VIP- (Figure 7) and the proportion of ChAT^+^ cells that are Nkx.2.1-flp/ChAT-cre/RC::FLTG ones would improve the manuscript. As another example, in Figure 3G, the statistical test and p value to demonstrate that SOM^+^ neurons show more frequent responses and the number of mice contributing to the data should be specified. For all experiments, the number of sections or cells analyzed, the number of mice contributing to the data, the statistical test and p values and so on should be clearly stated.

Revisions for this paper or a follow-up:

Working on the assumption that new experiments are not possible under current conditions, any existing experimental results testing the effects of uptake blockers or focused on mAChRs would also add to the manuscript. Did the authors attempt to use uptake blockers and or explore muscarinic versus nicotinic responses in any detail to determine if point-to-point transmission is not the main means of communication of ACh? The punctate and presynaptic terminal expression would argue against this, but the small amplitude of currents detected by optogenetics suggests that this may not be a primary mode of transmission. Similarly, in paragraph three of subsection "Cortical VIP^+^/ChAT^+^ neurons robustly release GABA onto inhibitory interneurons and sparsely

release ACh" the authors suggest that a subtype of layer 1 neurons receives ACh responses. As there are distinct types of layer 1 interneurons (e.g. Schuman et al., 2019), any electrophysiological and/or morphological phenotyping of the postsynaptic cell type would provide more compelling evidence for the conclusion, that a highly specific subnetwork in L1 is targeted by VIP/ChAT interneurons.
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Author response

> Revisions expected for this paper:
>
> Overall, all three reviewers agreed that the experiments were well designed and well executed. One major concern related to the lack of explicit comparisons between M1 and PFC in some experiments (like the array tomography experiments) and clarifying the laminar and areal locations of other experiments as these areal and laminar differences are presented as major findings of the paper.

We have attempted to address these concerns by, whenever possible, including such information. We now note the areal locations of the analyses we are performing, and added additional accounting of laminar positions of all cells we recorded from, and where possible, of the pre-synaptic terminals we characterize.

Nevertheless, we do not believe laminar differences between pre-synaptic terminal neurotransmitter expression or synaptic connectivity explain the differences in ACh vs. GABA release. Layer 1 interneurons showed among the highest rates of ACh connectivity, but we think this is a feature of layer 1 interneurons as a cell type, and not as a specific laminar enrichment of ACh release. Layer 1 is unique in that it lacks pyramidal neurons, and for the most part the SOM^+^ and PV^+^ interneurons that span the other cortical layers.

> Additional analyses explicitly comparing array tomography images between M1 and PFC and from layer 1 and other layers (laminar distribution) would significantly strengthen the manuscript.

Unfortunately, given the shutdown of all lab operations and core facilities as a result of the COVID-19 pandemic, we are currently unable to perform any additional array tomography experiments. Even as lab operations ramp back up, it will be an unknown amount of time until we are able to make use of core facility services that we would require for additional array tomography experiments.

Beyond this logistical constraint, there are other practical concerns that make these experiments infeasible. Each image stack of array tomography data only covers \~200 x 250 microns of cortical tissue. Therefore, in order to compare array tomography between layers, spanning the entire cortical column across multiple replicates, would require dramatically scaling up the throughput of our array tomography data acquisition beyond the capabilities of our facility. To our knowledge, such large-scale, high-throughput array tomography experiments are rare outside of the Allen Institute.

Additionally, we are dubious of the specific hypothesis answered by comparing array tomography between M1 and mPFC. Our array tomography experiments are meant to specifically address the VIP^+^/ChAT^+^ interneuron population. We show that the connectivity difference between M1 and mPFC are due to the presence of non-VIP, ChAT^+^ neurons in the mPFC. Therefore any comparison of VIP^+^/ChAT^+^ pre-synaptic terminals between mPFC and M1 with array tomography would require intersectional genetics to disambiguate the contribution of these two cell types, without any evidence a priori for a difference within VIP^+^/ChAT^+^ interneurons across brain regions.

However, we do have data pertaining to the laminar distribution of VAChT and VGAT-expressing terminals from VIP^+^/ChAT^+^ neurons in motor cortex from the immunohistochemistry experiments described in Figure 5. We have included this additional analyses in Figure 5---figure supplement 1. Contrary to expectations from the synaptic connectivity data, we actually find a very slight (but significant) depletion of VAChT^+^ terminals in superficial layers, and enrichment of VGAT^+^ terminals. However, because the position of pre-synaptic terminals is not that informative for the position of the cells that receive those synapses (neurons of deep layers receive inputs onto their dendrites in layer 1), we do not draw any strong conclusions from these laminar distribution analysis. Still, we hope these additional analyses is helpful towards addressing the reviewers' concerns.

> Furthermore, reporting, for example, the layer breakdown of the recordings from inhibitory neurons in Figure 3G and the layer and areal locations of the data analyzed in Figures 4 and 5 would improve the manuscript.

We have added the laminar positions of all recordings from 3G as supplemental data in Figure 3---figure supplement 1, as well as the areal locations of the all data for Figures 4 and 5 as indicated in the text and figure legends, and laminar distribution of all terminals from Figure 5 are indicated in Figure 5---figure supplement 1.

> Reporting the data for M1 and PFC separately in Figure 6J and indicating how many neurons were recorded in both regions would also contribute to these comparisons.

We have changed Figure 6 to report the data separately for M1 and mPFC in Figure 6J as suggested, indicating the number of neurons recorded in both regions. Our reporting of cells recorded in gabazine has been moved to Figure 6---figure supplement 2.

> A second major concern was that some experiments lacked quantification or explicit descriptions of the quantification. For example, additional quantification such as reporting the proportion of ChAT^+^ neurons that are VIP- (Figure 7) and the proportion of ChAT^+^ cells that are Nkx.2.1-flp/ChAT-cre/RC::FLTG ones would improve the manuscript.

We have aimed to provide quantification wherever possible in the manuscript, but the uniquely sparse nature of the Nkx2.1/ChAT neurons (which are consistent with being the same as the non-VIP CHAT^+^ neurons) makes this difficult -- as only a small handful are present in any given mouse brain. Thus, for the whole brain the answer is going to be something like 3-5 VIP-/Chat+ cells compared to thousands of VIP+/Chat+ cells. If we analyze only the fields of view in which we find VIP-/Chat+ cells, this will erroneously give the impression that they are a high fraction of cells.

Therefore, we thought the most clear and correct way to describe the prevalence of these neurons is to merely report that we often did not find more than 3-5 in each mouse brain. We have also edited the text to make more clear that the non-VIP ChATs we observe through FISH and the genetically labeled Nkx2.1/ChAT-expressing neurons are similarly sparse and we believe to be the same population.

> As another example, in Figure 3G, the statistical test and p value to demonstrate that SOM^+^ neurons show more frequent responses and the number of mice contributing to the data should be specified. For all experiments, the number of sections or cells analyzed, the number of mice contributing to the data, the statistical test and p values and so on should be clearly stated.

We have now included the number of cells and mice contributing to each data set in the paper. Unfortunately, we do not have the exact number of slices for all physiology experiments.

We have also added Pearson's Chi-squared statistical p-values to report the likelihood that the differences in connectivity we observe in Figure 3 occurred by chance, and have added those p-values to the figure legend.

> Revisions for this paper or a follow-up:
>
> Working on the assumption that new experiments are not possible under current conditions, any existing experimental results testing the effects of uptake blockers or focused on mAChRs would also add to the manuscript. Did the authors attempt to use uptake blockers and or explore muscarinic versus nicotinic responses in any detail to determine if point-to-point transmission is not the main means of communication of ACh? The punctate and presynaptic terminal expression would argue against this, but the small amplitude of currents detected by optogenetics suggests that this may not be a primary mode of transmission.

We did perform extensive experiments to detect mAChR-mediated responses by stimulating with trains of blue light while recording in K^+^-internal solutions. We recorded over 200 hundred neurons, some in the presence of GABA-receptor antagonists (gabazine and CGP-35348) and ACh-esterase inhibitors (physostigmine) in order to boost our chances of observing ACh-mediated responses. These experiments were done using the *VIP^ires-Cre^ x Rosa26^lsl-ChR2-EYFP^* mouse line and have been added to the manuscript in Figure 6---figure supplement 2. One confusing part of this analysis is that our optogenetic stimulation often caused a depolarization that could be mistaken for mAChR-mediated responses. However, we found that these voltage changes could not be consistently blocked by ACh-receptor antagonists. They were blocked by TTX, but not rescued by 4AP. We also observed that they could not be blocked by Cd^2+^, indicating that these depolarization are not caused by synaptic release. We therefore concluded that these were ephaptic depolarizations occurring as a result of strongly activating VIP interneuron axons. As these experiments do not add to our major findings, we have limited our explanation of these results to the Figure 5---figure supplement 1 figure legend.

> Similarly, in paragraph three of subsection "Cortical VIP^+^/ChAT^+^ neurons robustly release GABA onto inhibitory interneurons and sparsely release ACh" the authors suggest that a subtype of layer 1 neurons receives ACh responses. As there are distinct types of layer 1 interneurons (e.g. Schuman et al., 2019), any electrophysiological and/or morphological phenotyping of the postsynaptic cell type would provide more compelling evidence for the conclusion, that a highly specific subnetwork in L1 is targeted by VIP/ChAT interneurons.

Unfortunately, we do not have any further electrophysiological or morphological information about those layer 1 interneurons. We agree this data would be interesting, but electrophysiological characterization is not possible using the Cs^+^-based internal we used for screening nAChR-mediated responses. In the future we hope to perform morphological reconstruction of connected neurons.
